The overarching goal of the Neuroimaging and Biomarkers Core (NIBC) will be to bring together neuroimaging, plasma, cerebrospinal fluid (CSF), and other potentially relevant biomarkers to facilitate ADRC research projects and other ongoing studies, assist in initiating new projects, and encourage new investigators to benefit from the strengths in these areas at UCLA and at other institutions. Our ultimate goal - manifested in targeting subjects with pre-clinical cognitive changes and the interaction with Projects 1 and 2 - is to develop image acquisition, archiving, and analysis technologies to the point that they are valuable tools in the effort to support treatments that can delay, prevent, or slow the progression of degenerative brain diseases. The NIBC specific aims are: (1) Collect and archive longitudinal high-resolution structural MRI data on ADRC subjects. (2) Provide support for imaging analysis for longitudinal amyloid plaque and tau tangle (FDDNP) and Pittsburgh Compound-B (PIB) PET imaging on subjects enrolled in Project 2. (3) Interact with the Clinical Core and the Neuropathology Core in collecting plasma and tissue samples for planned proteomic and genomic studies, (plasma and CSF) (4) Provide the means for investigators to obtain rapid and reliable quantification and diagnostic interpretation of imaging data acquired from subjects or patients evaluated for mild cognitive dysfunction or dementia. (5) Support the other cores and projects of the ADRC, and promote the Therapeutic Imperative theme, activities, and mission of the ADRC. The Core is designed to leverage UCLA's current imaging research strengths, particularly in the development of new imaging methods and PET radioligands, and the DMSC has special biomarker systems support devoted to NIBC. Moreover, we recognize the critical importance of integrating informative imaging data with other relevant biomarkers. Given the important role of neuroimaging and biomarkers in current AD research within the ADRC and elsewhere, the NIBC will have a pivotal role in these investigations. The Core will interact with and support Project 1 (MRI biomarkers of incipient AD) and Project 2 (using both FDDNP and PIB and plasma and CSF biomarkers), as well as with the on-going research of the Jim Easton Consortium for Alzheimer's Drug Discovery and Biomarker Development at UCLA.

Public Health Relevance

Neuroimaging and other biomarkers have taken on an incrementally important role in advancing clinical research in Alzheimer's disease (AD) and providing key opportunities for translating basic science discoveries into clinical applications. The UCLA NIBC will bring together multiple biomarkers to better understand the peripheral indicators and brain imaging of Alzheimer's type brain disease.

National Institute of Health (NIH)
National Institute on Aging (NIA)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZAG1-ZIJ-4)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California Los Angeles
Los Angeles
United States
Zip Code
Chang, Timothy S; Teng, Edmond; Elashoff, David et al. (2016) Optimizing Effect Sizes With Imaging Enrichment and Outcome Choices for Mild Alzheimer Disease Clinical Trials. Alzheimer Dis Assoc Disord :
Green, Colin; Zhang, Shenqiu (2016) Predicting the progression of Alzheimer's disease dementia: A multidomain health policy model. Alzheimers Dement 12:776-85
Hohman, Timothy J; Cooke-Bailey, Jessica N; Reitz, Christiane et al. (2016) Global and local ancestry in African-Americans: Implications for Alzheimer's disease risk. Alzheimers Dement 12:233-43
Hohman, Timothy J; Bush, William S; Jiang, Lan et al. (2016) Discovery of gene-gene interactions across multiple independent data sets of late onset Alzheimer disease from the Alzheimer Disease Genetics Consortium. Neurobiol Aging 38:141-50
Ramirez, Leslie M; Goukasian, Naira; Porat, Shai et al. (2016) Common variants in ABCA7 and MS4A6A are associated with cortical and hippocampal atrophy. Neurobiol Aging 39:82-9
Filshtein, Teresa; Beckett, Laurel A; Godwin, Haley et al. (2016) Incident Antipsychotic Use in a Diverse Population with Dementia. J Am Geriatr Soc 64:e44-6
Clark, David Glenn; McLaughlin, Paula M; Woo, Ellen et al. (2016) Novel verbal fluency scores and structural brain imaging for prediction of cognitive outcome in mild cognitive impairment. Alzheimers Dement (Amst) 2:113-22
Lin, Amy; Brook, Jenny; Grill, Joshua D et al. (2016) Participant-Informant Relationships Affect Quality of Life Ratings in Incipient and Clinical Alzheimer Disease. Am J Geriatr Psychiatry :
Porat, Shai; Goukasian, Naira; Hwang, Kristy S et al. (2016) Dance Experience and Associations with Cortical Gray Matter Thickness in the Aging Population. Dement Geriatr Cogn Dis Extra 6:508-517
Mez, Jesse; Mukherjee, Shubhabrata; Thornton, Timothy et al. (2016) The executive prominent/memory prominent spectrum in Alzheimer's disease is highly heritable. Neurobiol Aging 41:115-21

Showing the most recent 10 out of 651 publications